Dr. Guglietta: Yes. So, it's exactly the challenge. And what we are actually seeing is that at the moment, especially for ...

The finding was further corroborated through genomic analyses of human samples. In a study of sporadic colorectal polyps, researchers found that 29% of the samples (30 out of 102) exhibited this ...

Oxford Drug Design Ltd. has announced additional in vivo validation for its novel approach against cancer. The innovative approach, using generative AI capabilities, is based on the novel target ...